Book a Meeting


An archive of ADCC/CDC-enhanced biobetter antibodies developed by Creative Biolabs' state-of-the-art technology platform.


ADCC-Enhanced Biobetters

ADCC-Enhanced Biobetter is a class of therapeutic biological antibodies that are not fucosylated. Creative Biolabs has an advanced Afuco™ technology platform that can control the glycosylation level of antibodies, achieving ADCC enhancement by reducing fucosylation in the Fc region of the antibody. This class of antibodies is a biological drug that increases the binding affinity of the FcyR receptor to immune effector cells. More specifically, DNA recombinant technology is used to produce this fucosylated therapeutic ADCC-Enhanced. It is produced in CHO cells lacking fucosylation and purified by affinity chromatography of protein G.

Please search below for your ADCC-Enhanced Biobetter antibody of interest. Or contact us directly to tailor a solution to your specific needs.

Search for more products.



Biobetter Antibodies Betting on the Future Creative Biolabs  Visit

All products and services are for Research Use Only. Do Not use in humans.